[vc_row gap=”20″][vc_column css_animation=”fadeInLeft” width=”1/3″][ult_sticky_section sticky_gutter=”150″]
[vc_empty_space height=”10″][vc_empty_space height=”10px”]Treatments[vc_empty_space height=”10px”][vc_row_inner][vc_column_inner offset=”vc_hidden-sm vc_hidden-xs”][vc_widget_sidebar show_bg=”false” sidebar_id=”sidebar_3″][/vc_column_inner][/vc_row_inner][/ult_sticky_section][/vc_column][vc_column width=”2/3″]TNBC accounts for approximately 10-15% of all breast cancer cases. It tends to occur more frequently in younger women, African-American women, and those with BRCA1 gene mutations.
TNBC is clinically and genetically diverse, making it a challenging disease to treat. It tends to be more aggressive and have a higher likelihood of recurrence compared to other breast cancer subtypes. However, it also has a higher response rate to chemotherapy.
Treatment options for TNBC typically include surgery to remove the tumor, followed by adjuvant chemotherapy to destroy any remaining cancer cells. Radiation therapy may also be recommended after surgery to reduce the risk of local recurrence. In some cases, neoadjuvant chemotherapy (chemotherapy before surgery) may be used to shrink the tumor and increase the chances of successful surgery.
Research into new treatment approaches for TNBC is ongoing, including targeted therapies and immunotherapies that aim to exploit the specific molecular characteristics of TNBC.
Supportive care and a multidisciplinary approach involving oncologists, surgeons, radiation oncologists, and other healthcare professionals are essential in managing TNBC. Regular follow-up visits, surveillance imaging, and monitoring for potential late effects or recurrence are important for long-term care.
Given the unique characteristics of TNBC, individuals diagnosed with this subtype of breast cancer may benefit from personalized treatment plans and participation in clinical trials to access innovative therapies and contribute to advancing knowledge in the field.[/vc_column_text][vc_row_inner el_id=”doctor-and-specialist”][vc_column_inner][vc_widget_sidebar show_bg=”false” sidebar_id=”sidebar_4″][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner]
Medical oncologists are medical professionals who have completed a medical degree followed by a residency program in internal medicine, and subsequent fellowship training in medical oncology. They possess specialized knowledge and expertise in the diagnosis and management of cancer using systemic treatments such as chemotherapy, targeted therapy, and immunotherapy. Medical oncologists play a central role in the treatment of TNBC by designing and overseeing the administration of appropriate chemotherapy regimens or targeted therapies, which may be given before surgery (neoadjuvant), after surgery (adjuvant), or in advanced stages of the disease.
Surgical oncologists are doctors who have completed a medical degree followed by a residency program in general surgery, and subsequent fellowship training in surgical oncology. They specialize in the surgical treatment of cancer. Surgical oncologists are involved in the management of TNBC by performing breast surgery, such as lumpectomy or mastectomy, and evaluating the extent of the disease through lymph node dissection or sentinel lymph node biopsy. They work closely with medical oncologists to ensure comprehensive and coordinated care for TNBC patients.
In addition to medical and surgical oncologists, a multidisciplinary team of healthcare professionals may be involved in the care of TNBC patients. This team may include radiation oncologists, pathologists, radiologists, genetic counselors, and specialized nurses who provide supportive care and assist in treatment decision-making.
The treatment of TNBC is complex and often requires a combination of different therapies tailored to the individual patient’s needs. The expertise of medical oncologists and surgical oncologists is critical in determining the most appropriate treatment approach for TNBC patients, considering factors such as tumor stage, patient characteristics, and molecular profiling.
In summary, medical oncologists and surgical oncologists are the specialized doctors who diagnose and treat triple-negative breast cancer. They utilize their expertise in medical oncology and surgical oncology, respectively, to accurately diagnose the condition, develop personalized treatment plans, and provide ongoing care and support to individuals with TNBC, aiming to achieve optimal treatment outcomes and improve patient survival and quality of life.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner disable_element=”yes”][vc_column_inner][vc_cta h2=”Doctor and Specialists” h2_font_container=”tag:h3|text_align:left” h2_use_theme_fonts=”yes” h4_font_container=”tag:h4|text_align:left” add_icon=”top” i_icon_fontawesome=”fas fa-heartbeat” i_size=”xl” i_css_animation=”fadeInLeft” css_animation=”fadeIn” use_custom_fonts_h2=”true” use_custom_fonts_h4=”true”]Dermatologists are doctors or physicians who specialize in the diagnosis and treatment of skin conditions, including acne. They are trained to identify the different types of acne and their underlying causes, as well as to develop personalized treatment plans for their patients based on the severity of their condition and their individual needs. Dermatologists may also perform procedures such as extractions, chemical peels, and light therapies to treat acne and improve the appearance of the skin.
In addition to dermatologists, primary care physicians, pediatricians, and gynecologists may also treat acne in their patients, particularly those with milder forms of the condition. However, for more severe cases or those that do not respond to initial treatments, a referral to a dermatologist may be necessary to ensure appropriate management of the condition. Patients with acne may also seek the advice of an esthetician, who can provide guidance on skin care routines and recommend over-the-counter products to help manage the condition.[/vc_cta][/vc_column_inner][/vc_row_inner][vc_row_inner el_id=”treatments”][vc_column_inner][vc_single_image source=”featured_image” img_size=”500×200″][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner]
Surgery: The primary treatment for TNBC is typically surgery to remove the tumor. This may involve a lumpectomy (removal of the tumor and a small portion of surrounding tissue) or a mastectomy (removal of the entire breast). Lymph node removal or biopsy may also be performed to determine if the cancer has spread.
Chemotherapy: TNBC is often treated with chemotherapy, as this cancer subtype is less likely to respond to hormonal therapy or targeted therapies. Various chemotherapy drugs may be used, either before surgery (neoadjuvant) or after surgery (adjuvant), to destroy cancer cells and reduce the risk of recurrence.
Radiation therapy: Radiation therapy may be recommended after surgery to target any remaining cancer cells and reduce the risk of local recurrence. It involves the use of high-energy X-rays or other radiation sources to kill cancer cells.
Targeted therapies (under clinical trials): Researchers are actively studying and developing targeted therapies specifically for TNBC. These treatments aim to target specific molecular abnormalities present in TNBC cells, such as PARP inhibitors or immune checkpoint inhibitors. However, their use is still largely investigational and typically limited to clinical trial settings.
Clinical trials: Participation in clinical trials can provide access to novel treatment options and contribute to advancements in TNBC treatment.
Treatment decisions for TNBC should be made in consultation with a multidisciplinary team, including oncologists, surgeons, and radiation therapists, who can provide personalized recommendations based on the specific characteristics of the tumor, the stage of the cancer, and the individual’s overall health. Ongoing monitoring and follow-up are crucial to assess treatment response and detect any potential recurrence.[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]
